Guideline Adaptation: An Appealing Alternative to De Novo Guideline Development
Notice bibliographique
Résumé
Letters1 April 2008Guideline Adaptation: An Appealing Alternative to De Novo Guideline DevelopmentBeatrice Fervers, MD, MSc, Magali Remy-Stockinger, Msc, Ian D. Graham, PhD, Bernard Burnand, MD, MPH, Margaret Harrison, RN, PhD, George Browman, MD, MSc, and Jean Latreille, MDMBeatrice Fervers, MD, MScFrom Centre Léon Berard, Lyon F-69373, France; Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada; University of Lausanne, CH-1005 Lausanne, Switzerland; Queen's University, Ottawa, Ontario K7L 3N6, Canada; British Columbia Cancer Agency, Vancouver, British Columbia V6H 2E3, Canada; and Hôpital Charles LeMoyne, Longueuil, Québec J4V 2H1, Canada.Search for more papers by this author, Magali Remy-Stockinger, MscFrom Centre Léon Berard, Lyon F-69373, France; Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada; University of Lausanne, CH-1005 Lausanne, Switzerland; Queen's University, Ottawa, Ontario K7L 3N6, Canada; British Columbia Cancer Agency, Vancouver, British Columbia V6H 2E3, Canada; and Hôpital Charles LeMoyne, Longueuil, Québec J4V 2H1, Canada.Search for more papers by this author, Ian D. Graham, PhDFrom Centre Léon Berard, Lyon F-69373, France; Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada; University of Lausanne, CH-1005 Lausanne, Switzerland; Queen's University, Ottawa, Ontario K7L 3N6, Canada; British Columbia Cancer Agency, Vancouver, British Columbia V6H 2E3, Canada; and Hôpital Charles LeMoyne, Longueuil, Québec J4V 2H1, Canada.Search for more papers by this author, Bernard Burnand, MD, MPHFrom Centre Léon Berard, Lyon F-69373, France; Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada; University of Lausanne, CH-1005 Lausanne, Switzerland; Queen's University, Ottawa, Ontario K7L 3N6, Canada; British Columbia Cancer Agency, Vancouver, British Columbia V6H 2E3, Canada; and Hôpital Charles LeMoyne, Longueuil, Québec J4V 2H1, Canada.Search for more papers by this author, Margaret Harrison, RN, PhDFrom Centre Léon Berard, Lyon F-69373, France; Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada; University of Lausanne, CH-1005 Lausanne, Switzerland; Queen's University, Ottawa, Ontario K7L 3N6, Canada; British Columbia Cancer Agency, Vancouver, British Columbia V6H 2E3, Canada; and Hôpital Charles LeMoyne, Longueuil, Québec J4V 2H1, Canada.Search for more papers by this author, George Browman, MD, MScFrom Centre Léon Berard, Lyon F-69373, France; Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada; University of Lausanne, CH-1005 Lausanne, Switzerland; Queen's University, Ottawa, Ontario K7L 3N6, Canada; British Columbia Cancer Agency, Vancouver, British Columbia V6H 2E3, Canada; and Hôpital Charles LeMoyne, Longueuil, Québec J4V 2H1, Canada.Search for more papers by this author, and Jean Latreille, MDMFrom Centre Léon Berard, Lyon F-69373, France; Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada; University of Lausanne, CH-1005 Lausanne, Switzerland; Queen's University, Ottawa, Ontario K7L 3N6, Canada; British Columbia Cancer Agency, Vancouver, British Columbia V6H 2E3, Canada; and Hôpital Charles LeMoyne, Longueuil, Québec J4V 2H1, Canada.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-148-7-200804010-00021 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The ADAPTE Collaboration (www.adapte.org) is an international group aiming to enhance the use of evidence through more efficient development and implementation of guidelines by guideline adaptation. We read with great interest about the process used by the American College of Physicians (ACP) to develop their statement for glycemic control (1). The development and maintenance of high-quality guidelines require substantial time, expertise, and resources, and the ACP has used an attractive alternative to de novo guideline development. Yet guideline adaptation also presents challenges. Although guideline developers often consider existing guidelines as a source of evidence, few are using ...References1. Qaseem A, Vijan S, Snow V, Cross T, Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med. 2007;147:417-22. [PMID: 17876024] LinkGoogle Scholar2. Graham ID, Harrison MB, Brouwers M, Davies BL, Dunn S. Facilitating the use of evidence in practice: evaluating and adapting clinical practice guidelines for local use by health care organizations. J Obstet Gynecol Neonatal Nurs. 2002;31:599-611. [PMID: 12353740] CrossrefMedlineGoogle Scholar3. Fervers B, Burgers JS, Haugh MC, Latreille J, Mlika-Cabanne N, Paquet L, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care. 2006;18:167-76. [PMID: 16766601] CrossrefMedlineGoogle Scholar4. Shekelle P, Eccles MP, Grimshaw JM, Woolf SH. When should clinical guidelines be updated? BMJ. 2001;323:155-7. [PMID: 11463690] CrossrefMedlineGoogle Scholar5. Eisinger F, Geller G, Burke W, Holtzman NA. Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet. 1999;353:919-20. [PMID: 10094000] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Centre Léon Berard, Lyon F-69373, France; Canadian Institutes of Health Research, Ottawa, Ontario K1A 0W9, Canada; University of Lausanne, CH-1005 Lausanne, Switzerland; Queen's University, Ottawa, Ontario K7L 3N6, Canada; British Columbia Cancer Agency, Vancouver, British Columbia V6H 2E3, Canada; and Hôpital Charles LeMoyne, Longueuil, Québec J4V 2H1, Canada.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoGlycemic Control and Type 2 Diabetes Mellitus: The Optimal Hemoglobin A1c Targets. A Guidance Statement from the American College of Physicians Amir Qaseem , Sandeep Vijan , Vincenza Snow , J. Thomas Cross , Kevin B. Weiss , Douglas K. Owens , and Guideline Adaptation: An Appealing Alternative to De Novo Guideline Development Valerie A. Palda , Ian D. Graham , Dave Davis , Jako Burgers , Melissa Brouwers , Françoise Cluzeau , and Guideline Adaptation: An Appealing Alternative to De Novo Guideline Development Amir Qaseem , Vincenza Snow , and Douglas Owens Metrics Cited ByGuidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised EditionDiagnosis and Treatment of Helicobacter Pylori Infection: Korean and Overseas GuidelinesHistorical Perspective of Helicobacter pylori Treatment in KoreaGuidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised editionGuidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea, 2013 Revised EditionKDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD–Mineral and Bone Disorder (CKD-MBD)The Systematic Guideline Review: Method, rationale, and test on chronic heart failure 1 April 2008Volume 148, Issue 7Page: 563-564KeywordsConflicts of interestResearch quality assessmentResearch reporting guidelines ePublished: 1 April 2008 Issue Published: 1 April 2008 CopyrightCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,155 | 0,356 |
| Méta-épidémiologie (sens strict) | 0,001 | 0,001 |
| Méta-épidémiologie (sens large) | 0,002 | 0,002 |
| Bibliométrie | 0,007 | 0,004 |
| Études des sciences et des technologies | 0,002 | 0,004 |
| Communication savante | 0,010 | 0,013 |
| Science ouverte | 0,004 | 0,010 |
| Intégrité de la recherche | 0,013 | 0,015 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,020 | 0,006 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».